Duato Joaquin 4
4 · JOHNSON & JOHNSON · Filed Aug 25, 2025
Insider Transaction Report
Form 4
Duato Joaquin
DirectorCEO and Chairman of the Board
Transactions
- Exercise/Conversion
Common Stock
2025-08-22$101.87/sh+125,824$12,817,691→ 401,791 total - Exercise/Conversion
Employee Stock Options (Right to Buy)
2025-08-22$101.87/sh−125,824$12,817,691→ 0 totalExercise: $101.87From: 2019-02-09Exp: 2026-02-08→ Common Stock (125,824 underlying) - Sale
Common Stock
2025-08-22$179.21/sh−125,824$22,548,655→ 275,967 total
Holdings
- 130,852(indirect: By Spouse)
Common Stock
- 974(indirect: By 401(k))
Common Stock
Footnotes (3)
- [F1]This transaction was executed in multiple trades at prices ranging from $178.985 to $179.37. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (7/31/2025).
- [F3]Vested and exercisable one day after the third anniversary of the date of the grant.